Veregen ointment approved
Veregen (sinecatechins) ointment, 15% has been approved for the topical treatment of external genital and perianal warts in immunocompetent patients 18 years and older. This botanical drug is a mixture of eight catechins, the primary phenols found in green tea leaves. In two Phase III trials, Veregen proved effective in clearing both baseline and newly emerging external genital and perianal warts, with complete clearance in 53.6% of all patients studied who received Veregen (as compared to 35.3% of those patients receiving vehicle).
Bradley Pharmaceuticals plans on making Veregen available by prescription within a few weeks.
For more information call (973) 882-1505 or visit www.bradpharm.com.